Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

for
Common Warts, Common Warts (Verruca Vulgaris),
Location: Brighton MA, West Palm Beach FL, Sweetwater FL,
Sponsor: Verrica Pharmaceuticals Inc.

Sex: All

Age: 2+

Code: NCT07637734

Phase 3, Recruiting

A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

for
Human Papilloma Virus (HPV),
Location: Columbus OH, Mobile AL, Little Rock AR, Saint Paul MN,
Sponsor: Daré Bioscience, Inc.

Sex: Female

Age: 22 - 50

Code: NCT07601074

Phase 2, Recruiting

Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness

for
Influenza (Healthy Volunteers)
Location: Halifax
Sponsor: Dalhousie University

Sex: All

Age: 18 - 45

Code: NCT07305207

Phase 1, Recruiting

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

for
HER2-negative Breast Cancer, Hormone Receptor Positive Tumor,
Location: Port Huron MI, Mount Clemens MI, Detroit MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 22+

Code: NCT07227831

Recruiting

To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

for
Locally Advanced or Metastatic HER2-Expressing Cancers
Location: Duarte CA, Palo Alto CA
Sponsor: Vir Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT05356741

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

for
HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma,
Location: The Bronx NY, Durham NC, San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06774027

Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Lake Success NY, Fairfax VA, Rochester NY, Detroit MI,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase 1, Phase 2, Recruiting

Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic

for
HIV Testing, HEPATITIS C (HCV), Syphilis,
Location: Harpers Ferry WV
Sponsor: West Virginia University

Sex: All

Age: 18+

Code: NCT07317687

Recruiting

Rash & Diarrhea Prophylaxis With Capivasertib

for
Metastatic HR+/HER2- Breast Cancer
Location: New Haven CT
Sponsor: Maryam Lustberg

Sex: All

Age: 18+

Code: NCT07426822

Phase 2, Recruiting

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

for
Influenza, Community-acquired Pneumonia, Cardiovascular Events
Location: Oakland CA
Sponsor: Kaiser Permanente

Sex: All

Age: 65+

Code: NCT06029933

Recruiting

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

for
ER-Positive HER2-Negative Breast Cancer
Location: Marietta GA, Edgewood KY, Kingwood TX, Fort Worth TX
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07647328

Phase 3, Recruiting

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

for
Head and Neck Carcinoma of Unknown Primary,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04754321

Phase 1, Recruiting

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07407920

Phase 2, Recruiting

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

for
Brain Cancer, Brain Metastases, Melanoma, Lung Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT04899908

Phase 2, Recruiting

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

for
Influenza, Human+COVID-19
Location: Newport News VA, Charlottesville VA, West Palm Beach FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 65 - 70+

Code: NCT07464314

Phase 1, Recruiting

ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

for
HER2 Low Breast Carcinoma, Triple Negative Breast Cancer,
Location: San Francisco CA
Sponsor: Laura Huppert, MD, BA

Sex: All

Age: 18+

Code: NCT06224673

Phase 2, Recruiting

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Non-small Cell Lung Cancer, EGFR Mutation,
Location: Nashville TN
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT05099172

Phase 1, Phase 2, Recruiting

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Chicago IL, Warrenville IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07178301

Phase 2, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Shirley NY, Stony Brook NY, Danbury CT, Mineola NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase 3, Recruiting

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

for
Squamous Cell Carcinoma, Human Papilloma Virus (HPV),
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07513389

Phase 2, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial